

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 8.56745081 |
| 2 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 8.56745081 |
| 3 | positive regulation of interleukin-17 production (GO:0032740) | 8.25176735 |
| 4 | positive regulation of natural killer cell differentiation (GO:0032825) | 8.20914526 |
| 5 | * positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 8.08721981 |
| 6 | regulation of natural killer cell mediated immunity (GO:0002715) | 7.65588084 |
| 7 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 7.65588084 |
| 8 | positive regulation of organelle assembly (GO:1902117) | 7.32379253 |
| 9 | regulation of lymphocyte chemotaxis (GO:1901623) | 7.28979204 |
| 10 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 7.01705995 |
| 11 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 6.99975367 |
| 12 | positive regulation of T cell chemotaxis (GO:0010820) | 6.98046856 |
| 13 | regulation of T cell chemotaxis (GO:0010819) | 6.98046856 |
| 14 | activated T cell proliferation (GO:0050798) | 6.93232522 |
| 15 | * positive regulation of cell killing (GO:0031343) | 6.52262164 |
| 16 | regulation of natural killer cell differentiation (GO:0032823) | 6.19773088 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.14299887 |
| 18 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 6.07989027 |
| 19 | dendritic cell differentiation (GO:0097028) | 6.04949966 |
| 20 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.92495796 |
| 21 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 5.81823342 |
| 22 | positive regulation of immune response to tumor cell (GO:0002839) | 5.67697211 |
| 23 | regulation of immune response to tumor cell (GO:0002837) | 5.67697211 |
| 24 | regulation of response to tumor cell (GO:0002834) | 5.67697211 |
| 25 | positive regulation of response to tumor cell (GO:0002836) | 5.67697211 |
| 26 | embryonic placenta development (GO:0001892) | 5.64330120 |
| 27 | interferon-gamma production (GO:0032609) | 5.62062991 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 5.61700139 |
| 29 | * regulation of isotype switching to IgG isotypes (GO:0048302) | 5.55807766 |
| 30 | * regulation of cell killing (GO:0031341) | 5.55806924 |
| 31 | * regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 5.48651913 |
| 32 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.48540705 |
| 33 | * positive regulation of B cell mediated immunity (GO:0002714) | 5.48540705 |
| 34 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 5.29842835 |
| 35 | lymphocyte chemotaxis (GO:0048247) | 5.26593606 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.21859140 |
| 37 | regulation of podosome assembly (GO:0071801) | 5.19666740 |
| 38 | cellular extravasation (GO:0045123) | 5.00010323 |
| 39 | * regulation of interleukin-17 production (GO:0032660) | 4.91250973 |
| 40 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.90849251 |
| 41 | leukocyte aggregation (GO:0070486) | 4.89380551 |
| 42 | positive regulation of lymphocyte migration (GO:2000403) | 4.86588452 |
| 43 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 4.82948546 |
| 44 | regulation of immunoglobulin secretion (GO:0051023) | 4.79704132 |
| 45 | macrophage activation (GO:0042116) | 4.79142315 |
| 46 | myeloid dendritic cell differentiation (GO:0043011) | 4.75094838 |
| 47 | response to interleukin-15 (GO:0070672) | 4.70282281 |
| 48 | positive regulation of humoral immune response (GO:0002922) | 4.70065742 |
| 49 | negative regulation of macrophage differentiation (GO:0045650) | 4.67645453 |
| 50 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.65131445 |
| 51 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.55965843 |
| 52 | * positive regulation of isotype switching (GO:0045830) | 4.55051732 |
| 53 | maturation of 5.8S rRNA (GO:0000460) | 4.54852283 |
| 54 | viral mRNA export from host cell nucleus (GO:0046784) | 4.54607627 |
| 55 | positive regulation of interleukin-10 production (GO:0032733) | 4.49767147 |
| 56 | T cell migration (GO:0072678) | 4.43865311 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.31590279 |
| 58 | * positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 4.25321848 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25105632 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.25105632 |
| 61 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.23459212 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 4.21106892 |
| 63 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.20810957 |
| 64 | * positive regulation of osteoclast differentiation (GO:0045672) | 4.15181859 |
| 65 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.15105877 |
| 66 | positive regulation of T cell cytokine production (GO:0002726) | 4.13360278 |
| 67 | T cell costimulation (GO:0031295) | 4.12561656 |
| 68 | positive regulation of cytokine production involved in immune response (GO:0002720) | 4.10341222 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.09366105 |
| 70 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 4.06245832 |
| 71 | * positive regulation of leukocyte mediated immunity (GO:0002705) | 4.04303625 |
| 72 | lymphocyte costimulation (GO:0031294) | 4.03190548 |
| 73 | negative T cell selection (GO:0043383) | 3.93368749 |
| 74 | * regulation of B cell mediated immunity (GO:0002712) | 3.91118669 |
| 75 | negative regulation of T cell mediated immunity (GO:0002710) | 3.90517675 |
| 76 | positive regulation of interferon-gamma production (GO:0032729) | 3.90394018 |
| 77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.89317136 |
| 78 | negative regulation of cell killing (GO:0031342) | 3.89317136 |
| 79 | cytidine deamination (GO:0009972) | 3.87347114 |
| 80 | cytidine metabolic process (GO:0046087) | 3.87347114 |
| 81 | cytidine catabolic process (GO:0006216) | 3.87347114 |
| 82 | positive T cell selection (GO:0043368) | 3.86310718 |
| 83 | regulation of natural killer cell activation (GO:0032814) | 3.85891721 |
| 84 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.85590738 |
| 85 | lymphocyte migration (GO:0072676) | 3.83338858 |
| 86 | * regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 3.82177848 |
| 87 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.78764062 |
| 88 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.75518736 |
| 89 | * positive regulation of DNA recombination (GO:0045911) | 3.75480609 |
| 90 | negative regulation of T cell proliferation (GO:0042130) | 3.72535700 |
| 91 | negative regulation by host of viral transcription (GO:0043922) | 3.71623913 |
| 92 | regulation of gamma-delta T cell activation (GO:0046643) | 3.71314414 |
| 93 | regulation of lymphocyte migration (GO:2000401) | 3.71271327 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.70977507 |
| 95 | * regulation of lymphocyte mediated immunity (GO:0002706) | 3.70455966 |
| 96 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.67998388 |
| 97 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.67004570 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 3.66351263 |
| 99 | inflammatory response to antigenic stimulus (GO:0002437) | 3.65288903 |
| 100 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.63045605 |
| 101 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240) | 3.62735842 |
| 102 | negative regulation of signal transduction in absence of ligand (GO:1901099) | 3.62735842 |
| 103 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62412743 |
| 104 | retinal cone cell development (GO:0046549) | 3.62173043 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.61435156 |
| 106 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.60533768 |
| 107 | T cell receptor signaling pathway (GO:0050852) | 3.59635129 |
| 108 | regulation of memory T cell differentiation (GO:0043380) | 3.56033919 |
| 109 | lymphocyte apoptotic process (GO:0070227) | 3.54321791 |
| 110 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.53730010 |
| 111 | * positive regulation of immunoglobulin production (GO:0002639) | 3.53393735 |
| 112 | tolerance induction (GO:0002507) | 3.48336772 |
| 113 | * positive regulation of JAK-STAT cascade (GO:0046427) | 3.48065061 |
| 114 | T cell apoptotic process (GO:0070231) | 3.45720121 |
| 115 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.45690481 |
| 116 | isotype switching (GO:0045190) | 3.45690481 |
| 117 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.45690481 |
| 118 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.44824371 |
| 119 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.43232169 |
| 120 | negative regulation of ligase activity (GO:0051352) | 3.43232169 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43082036 |
| 122 | * positive regulation of production of molecular mediator of immune response (GO:0002702) | 3.42591018 |
| 123 | positive regulation of defense response to virus by host (GO:0002230) | 3.41441303 |
| 124 | T cell proliferation (GO:0042098) | 3.41181177 |
| 125 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.40327120 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.38894271 |
| 127 | positive regulation of T cell migration (GO:2000406) | 3.37960867 |
| 128 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.37862584 |
| 129 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.35649597 |
| 130 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.32256216 |
| 131 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.32256216 |
| 132 | * alpha-beta T cell differentiation (GO:0046632) | 3.31700356 |
| 133 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.31105819 |
| 134 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.31105819 |
| 135 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.31105819 |
| 136 | positive regulation of B cell proliferation (GO:0030890) | 3.31073237 |
| 137 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.30847527 |
| 138 | DNA deamination (GO:0045006) | 3.29557424 |
| 139 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.28795655 |
| 140 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.22589698 |
| 141 | positive regulation of tissue remodeling (GO:0034105) | 3.18789717 |
| 142 | positive regulation of activated T cell proliferation (GO:0042104) | 3.17547037 |
| 143 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.16114463 |
| 144 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.16114463 |
| 145 | regulation of interferon-gamma production (GO:0032649) | 3.15566159 |
| 146 | regulation of interleukin-10 production (GO:0032653) | 3.15270632 |
| 147 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.11124614 |
| 148 | retinal rod cell development (GO:0046548) | 3.10616404 |
| 149 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.10127200 |
| 150 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.10019877 |
| 151 | regulation of protein kinase A signaling (GO:0010738) | 3.06311214 |
| 152 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.05539890 |
| 153 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.04061565 |
| 154 | regulation of chronic inflammatory response (GO:0002676) | 3.03906437 |
| 155 | Peyers patch development (GO:0048541) | 3.00697183 |
| 156 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.00697183 |
| 157 | regulation of cellular amine metabolic process (GO:0033238) | 2.99862067 |
| 158 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.98951274 |
| 159 | positive regulation of ligase activity (GO:0051351) | 2.94522093 |
| 160 | GDP-mannose metabolic process (GO:0019673) | 2.93330223 |
| 161 | negative regulation of B cell proliferation (GO:0030889) | 2.93029991 |
| 162 | * positive regulation of interleukin-12 production (GO:0032735) | 2.91906870 |
| 163 | negative regulation of mononuclear cell proliferation (GO:0032945) | 2.89670546 |
| 164 | negative regulation of lymphocyte proliferation (GO:0050672) | 2.89670546 |
| 165 | negative regulation of T cell activation (GO:0050868) | 2.89635240 |
| 166 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.85591853 |
| 167 | cornea development in camera-type eye (GO:0061303) | 2.84533664 |
| 168 | * alpha-beta T cell activation (GO:0046631) | 2.77268541 |
| 169 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 10.0380042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 8.35522908 |
| 2 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.55661676 |
| 3 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.79546765 |
| 4 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.47231337 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.34816279 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.09514731 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.91333266 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 3.62515232 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60318514 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.59131263 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.52180063 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.41295248 |
| 13 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 3.10823732 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.09912413 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.77799099 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.67555295 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.65797550 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.48198880 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.47109711 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.42858112 |
| 21 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.32248008 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.32026691 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11222368 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10308529 |
| 25 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.07352637 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05113970 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.03357403 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.02850453 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.02802791 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.1340906 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.97926027 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.95410526 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.93423304 |
| 34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.92374465 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.87514097 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82952460 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76509054 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.72113329 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68437819 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64863619 |
| 41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.59500184 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.56358839 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50185029 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49249575 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45843441 |
| 46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44522256 |
| 47 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44388081 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.43314935 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40341357 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40020900 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.38814405 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38513077 |
| 53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37773719 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36675782 |
| 55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.35950866 |
| 56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35045667 |
| 57 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33747350 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33422401 |
| 59 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33403425 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33053220 |
| 61 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.32454260 |
| 62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29561763 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.26468631 |
| 64 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.21824051 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21805984 |
| 66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21092954 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18464119 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17806981 |
| 69 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15935990 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15862759 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14523998 |
| 72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13126012 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12979383 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12266775 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07093408 |
| 76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05832785 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05322856 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04138195 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03118272 |
| 80 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.02277167 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01535688 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00205523 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98994249 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98308731 |
| 85 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97449421 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95873847 |
| 87 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95182890 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94743694 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94209521 |
| 90 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.94119180 |
| 91 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92881389 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92714977 |
| 93 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.92429782 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92246517 |
| 95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91954828 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.91521803 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91463236 |
| 98 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91400808 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90742725 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90655257 |
| 101 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.89511102 |
| 102 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.88385655 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86669070 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86640008 |
| 105 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86539047 |
| 106 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84934253 |
| 107 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84413749 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84212245 |
| 109 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83839537 |
| 110 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83125531 |
| 111 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.81992928 |
| 112 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.81981573 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81678080 |
| 114 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80934121 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80427481 |
| 116 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.80417179 |
| 117 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.79741172 |
| 118 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78880614 |
| 119 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.78189187 |
| 120 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.77980228 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77936844 |
| 122 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.75655006 |
| 123 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75497857 |
| 124 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.75305612 |
| 125 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.74955040 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74934589 |
| 127 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.73949766 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.73076415 |
| 129 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73073849 |
| 130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73006063 |
| 131 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.72343032 |
| 132 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.72145063 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71833759 |
| 134 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.71478994 |
| 135 | * GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.70753091 |
| 136 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.70140142 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69489222 |
| 138 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.69324543 |
| 139 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68803377 |
| 140 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.68523894 |
| 141 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.68004282 |
| 142 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.67977850 |
| 143 | GATA3_26560356_Chip-Seq_TH1_Human | 0.67692382 |
| 144 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67222723 |
| 145 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.65375253 |
| 146 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.64255093 |
| 147 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63663234 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63027601 |
| 149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.62449779 |
| 150 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.61379455 |
| 151 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.59893898 |
| 152 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.59510560 |
| 153 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.58878307 |
| 154 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58772756 |
| 155 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.58477085 |
| 156 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.58416265 |
| 157 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.57778210 |
| 158 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.56458033 |
| 159 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.56279395 |
| 160 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.55932738 |
| 161 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.55733602 |
| 162 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.55410761 |
| 163 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.55346357 |
| 164 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.54583630 |
| 165 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.53083383 |
| 166 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.51230841 |
| 167 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.51220101 |
| 168 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51142451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005671_abnormal_response_to | 6.81204519 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.07560641 |
| 3 | MP0003300_gastrointestinal_ulcer | 4.02804732 |
| 4 | * MP0001835_abnormal_antigen_presentation | 3.88886245 |
| 5 | * MP0009785_altered_susceptibility_to | 3.64324899 |
| 6 | * MP0005000_abnormal_immune_tolerance | 3.34806460 |
| 7 | MP0006082_CNS_inflammation | 3.28078745 |
| 8 | * MP0001800_abnormal_humoral_immune | 3.21982176 |
| 9 | * MP0002405_respiratory_system_inflammati | 3.06864254 |
| 10 | MP0005025_abnormal_response_to | 3.06398682 |
| 11 | MP0003436_decreased_susceptibility_to | 2.84385053 |
| 12 | * MP0002723_abnormal_immune_serum | 2.79386346 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.76485321 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.74335396 |
| 15 | MP0002398_abnormal_bone_marrow | 2.58701467 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.52610289 |
| 17 | * MP0001819_abnormal_immune_cell | 2.51491981 |
| 18 | MP0000716_abnormal_immune_system | 2.35118156 |
| 19 | MP0003045_fibrosis | 2.33987795 |
| 20 | MP0001958_emphysema | 2.33156248 |
| 21 | * MP0009333_abnormal_splenocyte_physiolog | 2.32681464 |
| 22 | MP0004782_abnormal_surfactant_physiolog | 2.27956287 |
| 23 | MP0001853_heart_inflammation | 2.24818311 |
| 24 | MP0005387_immune_system_phenotype | 2.07889151 |
| 25 | MP0001790_abnormal_immune_system | 2.07889151 |
| 26 | MP0000685_abnormal_immune_system | 2.01962818 |
| 27 | * MP0000689_abnormal_spleen_morphology | 2.01496655 |
| 28 | * MP0002419_abnormal_innate_immunity | 1.99915193 |
| 29 | * MP0000703_abnormal_thymus_morphology | 1.98725542 |
| 30 | * MP0002429_abnormal_blood_cell | 1.84801527 |
| 31 | * MP0002722_abnormal_immune_system | 1.82132337 |
| 32 | * MP0001845_abnormal_inflammatory_respons | 1.80238646 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.75562665 |
| 34 | * MP0010155_abnormal_intestine_physiology | 1.61363022 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.57179963 |
| 36 | MP0002933_joint_inflammation | 1.57138160 |
| 37 | MP0003724_increased_susceptibility_to | 1.56351813 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.52368902 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.51763532 |
| 40 | MP0009764_decreased_sensitivity_to | 1.51758723 |
| 41 | MP0002006_tumorigenesis | 1.51728401 |
| 42 | MP0004947_skin_inflammation | 1.50620430 |
| 43 | * MP0008469_abnormal_protein_level | 1.49572328 |
| 44 | MP0003329_amyloid_beta_deposits | 1.43997497 |
| 45 | * MP0005166_decreased_susceptibility_to | 1.40836043 |
| 46 | * MP0002148_abnormal_hypersensitivity_rea | 1.34781643 |
| 47 | MP0005085_abnormal_gallbladder_physiolo | 1.33988193 |
| 48 | * MP0003448_altered_tumor_morphology | 1.32404610 |
| 49 | MP0000604_amyloidosis | 1.26619083 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.25083324 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.21176080 |
| 52 | MP0004510_myositis | 1.20878250 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.16161044 |
| 54 | MP0001851_eye_inflammation | 1.13033597 |
| 55 | MP0005360_urolithiasis | 1.10168412 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.04009058 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.02278176 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.02085755 |
| 59 | MP0001984_abnormal_olfaction | 1.01255014 |
| 60 | MP0003303_peritoneal_inflammation | 1.01089099 |
| 61 | MP0003866_abnormal_defecation | 1.01015542 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.00489385 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.00197844 |
| 64 | MP0000920_abnormal_myelination | 0.96136599 |
| 65 | MP0005408_hypopigmentation | 0.96107128 |
| 66 | MP0000858_altered_metastatic_potential | 0.94207894 |
| 67 | MP0002139_abnormal_hepatobiliary_system | 0.92783465 |
| 68 | MP0000372_irregular_coat_pigmentation | 0.90698163 |
| 69 | MP0008872_abnormal_physiological_respon | 0.88919628 |
| 70 | MP0005076_abnormal_cell_differentiation | 0.88762976 |
| 71 | MP0002168_other_aberrant_phenotype | 0.86915190 |
| 72 | MP0002133_abnormal_respiratory_system | 0.82213198 |
| 73 | MP0005388_respiratory_system_phenotype | 0.82213198 |
| 74 | * MP0001663_abnormal_digestive_system | 0.81814404 |
| 75 | MP0005390_skeleton_phenotype | 0.80842464 |
| 76 | MP0004859_abnormal_synaptic_plasticity | 0.80332151 |
| 77 | * MP0001873_stomach_inflammation | 0.78611945 |
| 78 | * MP0002136_abnormal_kidney_physiology | 0.78329731 |
| 79 | MP0000249_abnormal_blood_vessel | 0.77394750 |
| 80 | MP0004142_abnormal_muscle_tone | 0.76959335 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 0.76918346 |
| 82 | MP0001502_abnormal_circadian_rhythm | 0.74855031 |
| 83 | * MP0002693_abnormal_pancreas_physiology | 0.73904518 |
| 84 | * MP0000609_abnormal_liver_physiology | 0.72887456 |
| 85 | MP0000569_abnormal_digit_pigmentation | 0.72532956 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.71637533 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.71447718 |
| 88 | * MP0010307_abnormal_tumor_latency | 0.71345864 |
| 89 | MP0009763_increased_sensitivity_to | 0.70855713 |
| 90 | MP0003195_calcinosis | 0.70115402 |
| 91 | MP0004130_abnormal_muscle_cell | 0.69117520 |
| 92 | MP0009697_abnormal_copulation | 0.68967075 |
| 93 | MP0001243_abnormal_dermal_layer | 0.67637361 |
| 94 | MP0001119_abnormal_female_reproductive | 0.64887038 |
| 95 | MP0002132_abnormal_respiratory_system | 0.64464535 |
| 96 | MP0009745_abnormal_behavioral_response | 0.63339671 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62922096 |
| 98 | MP0008873_increased_physiological_sensi | 0.61828672 |
| 99 | MP0001666_abnormal_nutrient_absorption | 0.60186431 |
| 100 | MP0004270_analgesia | 0.56291134 |
| 101 | * MP0002019_abnormal_tumor_incidence | 0.56107745 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.54140477 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.53751839 |
| 104 | MP0002089_abnormal_postnatal_growth/wei | 0.53720725 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.53417653 |
| 106 | MP0002163_abnormal_gland_morphology | 0.52709206 |
| 107 | MP0001915_intracranial_hemorrhage | 0.51251755 |
| 108 | MP0003943_abnormal_hepatobiliary_system | 0.49138768 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.47977960 |
| 110 | MP0003635_abnormal_synaptic_transmissio | 0.47839172 |
| 111 | MP0004197_abnormal_fetal_growth/weight/ | 0.45971817 |
| 112 | MP0000490_abnormal_crypts_of | 0.45630376 |
| 113 | MP0000613_abnormal_salivary_gland | 0.45470105 |
| 114 | MP0004233_abnormal_muscle_weight | 0.45459652 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.44471556 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.44296251 |
| 117 | * MP0009642_abnormal_blood_homeostasis | 0.44265021 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.44207305 |
| 119 | MP0010329_abnormal_lipoprotein_level | 0.44005862 |
| 120 | * MP0005381_digestive/alimentary_phenotyp | 0.43290582 |
| 121 | MP0005365_abnormal_bile_salt | 0.43181500 |
| 122 | MP0002210_abnormal_sex_determination | 0.42794672 |
| 123 | MP0001764_abnormal_homeostasis | 0.42428164 |
| 124 | MP0005332_abnormal_amino_acid | 0.41317188 |
| 125 | MP0005310_abnormal_salivary_gland | 0.41316348 |
| 126 | MP0001905_abnormal_dopamine_level | 0.41310260 |
| 127 | MP0005165_increased_susceptibility_to | 0.41181906 |
| 128 | MP0002736_abnormal_nociception_after | 0.40550877 |
| 129 | * MP0002083_premature_death | 0.40180515 |
| 130 | * MP0009643_abnormal_urine_homeostasis | 0.39503587 |
| 131 | * MP0000598_abnormal_liver_morphology | 0.39254902 |
| 132 | MP0003252_abnormal_bile_duct | 0.39078643 |
| 133 | MP0003453_abnormal_keratinocyte_physiol | 0.38416581 |
| 134 | MP0003795_abnormal_bone_structure | 0.38039593 |
| 135 | MP0001919_abnormal_reproductive_system | 0.35890348 |
| 136 | MP0002254_reproductive_system_inflammat | 0.35147042 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.34638852 |
| 138 | MP0001485_abnormal_pinna_reflex | 0.34039156 |
| 139 | MP0003880_abnormal_central_pattern | 0.33942312 |
| 140 | MP0001324_abnormal_eye_pigmentation | 0.31223733 |
| 141 | * MP0001881_abnormal_mammary_gland | 0.30310715 |
| 142 | MP0000383_abnormal_hair_follicle | 0.30054901 |
| 143 | MP0001849_ear_inflammation | 0.28135806 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.28042240 |
| 145 | MP0000427_abnormal_hair_cycle | 0.27230876 |
| 146 | MP0000639_abnormal_adrenal_gland | 0.26520654 |
| 147 | MP0000371_diluted_coat_color | 0.25903404 |
| 148 | MP0001968_abnormal_touch/_nociception | 0.25806301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.10389910 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.83149082 |
| 3 | Chronic diarrhea (HP:0002028) | 8.02933457 |
| 4 | IgA deficiency (HP:0002720) | 7.62863119 |
| 5 | Gastrointestinal infarctions (HP:0005244) | 7.30422040 |
| 6 | Abnormality of binocular vision (HP:0011514) | 5.33609634 |
| 7 | Diplopia (HP:0000651) | 5.33609634 |
| 8 | Inflammation of the large intestine (HP:0002037) | 4.99550846 |
| 9 | Gastrointestinal inflammation (HP:0004386) | 4.63602620 |
| 10 | Biconcave vertebral bodies (HP:0004586) | 4.48535924 |
| 11 | Stomatitis (HP:0010280) | 4.39205988 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.34879811 |
| 13 | Abnormality of T cells (HP:0002843) | 4.28883549 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.27449517 |
| 15 | Abnormality of the pons (HP:0007361) | 4.18631856 |
| 16 | Abnormality of the prostate (HP:0008775) | 4.14888997 |
| 17 | Joint swelling (HP:0001386) | 4.04822761 |
| 18 | Combined immunodeficiency (HP:0005387) | 3.96706909 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.94455935 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.92016736 |
| 21 | Delayed epiphyseal ossification (HP:0002663) | 3.91858092 |
| 22 | Arterial thrombosis (HP:0004420) | 3.89102616 |
| 23 | Amaurosis fugax (HP:0100576) | 3.87272672 |
| 24 | Pulmonary infiltrates (HP:0002113) | 3.82804346 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.77088967 |
| 26 | Hypoplasia of the pons (HP:0012110) | 3.73864088 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.67906502 |
| 28 | Rectal prolapse (HP:0002035) | 3.67724728 |
| 29 | Ureteral stenosis (HP:0000071) | 3.61370152 |
| 30 | Chest pain (HP:0100749) | 3.58335739 |
| 31 | Hypoplasia of the thymus (HP:0000778) | 3.56460169 |
| 32 | Increased IgM level (HP:0003496) | 3.52726273 |
| 33 | Hypoproteinemia (HP:0003075) | 3.52491304 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.52022901 |
| 35 | Obstructive lung disease (HP:0006536) | 3.52022901 |
| 36 | Carpal bone hypoplasia (HP:0001498) | 3.45652590 |
| 37 | Aortic dissection (HP:0002647) | 3.44410321 |
| 38 | Pulmonary embolism (HP:0002204) | 3.29169875 |
| 39 | IgG deficiency (HP:0004315) | 3.28661580 |
| 40 | Gangrene (HP:0100758) | 3.24936142 |
| 41 | Flat capital femoral epiphysis (HP:0003370) | 3.21756022 |
| 42 | Ureteral obstruction (HP:0006000) | 3.21421133 |
| 43 | Increased serum pyruvate (HP:0003542) | 3.16203440 |
| 44 | Birth length less than 3rd percentile (HP:0003561) | 3.15651647 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 3.15224481 |
| 46 | Thyroiditis (HP:0100646) | 3.05770485 |
| 47 | Abnormality of eosinophils (HP:0001879) | 3.05036700 |
| 48 | Vasculitis (HP:0002633) | 3.03607371 |
| 49 | Anorexia (HP:0002039) | 3.00002710 |
| 50 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.91965352 |
| 51 | Cheilitis (HP:0100825) | 2.84240569 |
| 52 | Submucous cleft hard palate (HP:0000176) | 2.83252120 |
| 53 | Oligomenorrhea (HP:0000876) | 2.73291624 |
| 54 | Myositis (HP:0100614) | 2.70241042 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.69257451 |
| 56 | Small epiphyses (HP:0010585) | 2.63472753 |
| 57 | Thrombocytosis (HP:0001894) | 2.61429853 |
| 58 | Abnormality of glycolysis (HP:0004366) | 2.60609573 |
| 59 | Abnormality of the lumbar spine (HP:0100712) | 2.57768372 |
| 60 | Cutaneous melanoma (HP:0012056) | 2.56154827 |
| 61 | Thrombophlebitis (HP:0004418) | 2.55696733 |
| 62 | Leukocytosis (HP:0001974) | 2.52464512 |
| 63 | Acute necrotizing encephalopathy (HP:0006965) | 2.51653910 |
| 64 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.49436168 |
| 65 | Acrocyanosis (HP:0001063) | 2.47315454 |
| 66 | Dilatation of the ascending aorta (HP:0005111) | 2.46216738 |
| 67 | Muscle fiber atrophy (HP:0100295) | 2.45409022 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.44153756 |
| 69 | IgM deficiency (HP:0002850) | 2.43125618 |
| 70 | Abnormal glucose tolerance (HP:0001952) | 2.42731287 |
| 71 | Recurrent viral infections (HP:0004429) | 2.42675001 |
| 72 | Meningitis (HP:0001287) | 2.41502857 |
| 73 | Periorbital edema (HP:0100539) | 2.41174992 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.41099025 |
| 75 | B lymphocytopenia (HP:0010976) | 2.41099025 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.40960753 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.40563877 |
| 78 | Facial edema (HP:0000282) | 2.40080596 |
| 79 | Hemoptysis (HP:0002105) | 2.40075494 |
| 80 | Deep palmar crease (HP:0006191) | 2.39884115 |
| 81 | Enlarged epiphyses (HP:0010580) | 2.38535640 |
| 82 | Mitochondrial inheritance (HP:0001427) | 2.36143204 |
| 83 | Hypoalbuminemia (HP:0003073) | 2.35762953 |
| 84 | Abnormal albumin level (HP:0012116) | 2.35762953 |
| 85 | Multiple enchondromatosis (HP:0005701) | 2.34700594 |
| 86 | Type I transferrin isoform profile (HP:0003642) | 2.34009805 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31081871 |
| 88 | Irregular vertebral endplates (HP:0003301) | 2.30561620 |
| 89 | Agammaglobulinemia (HP:0004432) | 2.30439163 |
| 90 | Type 2 muscle fiber atrophy (HP:0003554) | 2.29223530 |
| 91 | Abnormality of the pleura (HP:0002103) | 2.27977298 |
| 92 | Gingival bleeding (HP:0000225) | 2.27501702 |
| 93 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.26903326 |
| 94 | Absent epiphyses (HP:0010577) | 2.26903326 |
| 95 | Premature skin wrinkling (HP:0100678) | 2.23621866 |
| 96 | Metaphyseal irregularity (HP:0003025) | 2.23369807 |
| 97 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.22605420 |
| 98 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20697143 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20697143 |
| 100 | Lymphopenia (HP:0001888) | 2.18985936 |
| 101 | Opisthotonus (HP:0002179) | 2.18710412 |
| 102 | Alveolar cell carcinoma (HP:0006519) | 2.18182177 |
| 103 | Persistence of primary teeth (HP:0006335) | 2.16761904 |
| 104 | Lymphoma (HP:0002665) | 2.15879433 |
| 105 | Epistaxis (HP:0000421) | 2.15709561 |
| 106 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.15608457 |
| 107 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.14892042 |
| 108 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14690963 |
| 109 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.14472278 |
| 110 | Increased CSF lactate (HP:0002490) | 2.13817538 |
| 111 | Abnormality of the nasal septum (HP:0000419) | 2.12432931 |
| 112 | Keratitis (HP:0000491) | 2.12262642 |
| 113 | Loss of speech (HP:0002371) | 2.10085560 |
| 114 | Flat occiput (HP:0005469) | 2.08818839 |
| 115 | Premature graying of hair (HP:0002216) | 2.08300683 |
| 116 | Vertebral compression fractures (HP:0002953) | 2.07686630 |
| 117 | Optic neuritis (HP:0100653) | 2.06371996 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 2.06371996 |
| 119 | Glomerulopathy (HP:0100820) | 2.06348429 |
| 120 | Abnormality of the vertebral endplates (HP:0005106) | 2.04492647 |
| 121 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04327944 |
| 122 | Vertigo (HP:0002321) | 2.04168917 |
| 123 | Polyneuropathy (HP:0001271) | 2.03318802 |
| 124 | Aplastic anemia (HP:0001915) | 2.02231592 |
| 125 | Cerebral hypomyelination (HP:0006808) | 1.98408509 |
| 126 | Progressive macrocephaly (HP:0004481) | 1.96827655 |
| 127 | Bronchitis (HP:0012387) | 1.96072701 |
| 128 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.94052915 |
| 129 | Recurrent fungal infections (HP:0002841) | 1.93505640 |
| 130 | Alkalosis (HP:0001948) | 1.93341659 |
| 131 | Premature ovarian failure (HP:0008209) | 1.93198988 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 1.93125697 |
| 133 | Acute encephalopathy (HP:0006846) | 1.93074726 |
| 134 | Eosinophilia (HP:0001880) | 1.92856465 |
| 135 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92625327 |
| 136 | Pancreatitis (HP:0001733) | 1.91870331 |
| 137 | Optic disc pallor (HP:0000543) | 1.89605922 |
| 138 | Hypertensive crisis (HP:0100735) | 1.88299364 |
| 139 | Abnormality of male internal genitalia (HP:0000022) | 1.88054228 |
| 140 | Spastic diplegia (HP:0001264) | 1.86598178 |
| 141 | Orchitis (HP:0100796) | 1.86261892 |
| 142 | Pulmonary fibrosis (HP:0002206) | 1.86082513 |
| 143 | Neutropenia (HP:0001875) | 1.85293689 |
| 144 | Abnormal number of incisors (HP:0011064) | 1.84459670 |
| 145 | Hepatocellular necrosis (HP:0001404) | 1.84301524 |
| 146 | Optic nerve coloboma (HP:0000588) | 1.82723252 |
| 147 | Inability to walk (HP:0002540) | 1.81637394 |
| 148 | Autoimmune thrombocytopenia (HP:0001973) | 1.81359536 |
| 149 | Abnormality of the pericardium (HP:0001697) | 1.81259812 |
| 150 | Nasal polyposis (HP:0100582) | 1.80384924 |
| 151 | Abnormal platelet volume (HP:0011876) | 1.74353612 |
| 152 | Glucose intolerance (HP:0000833) | 1.73940542 |
| 153 | Restrictive lung disease (HP:0002091) | 1.72467531 |
| 154 | Thoracolumbar scoliosis (HP:0002944) | 1.70953665 |
| 155 | Sepsis (HP:0100806) | 1.69221715 |
| 156 | Entropion (HP:0000621) | 1.67854402 |
| 157 | Scanning speech (HP:0002168) | 1.66137420 |
| 158 | Redundant skin (HP:0001582) | 1.64999389 |
| 159 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.63087256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.37741234 |
| 2 | MAP3K12 | 6.30519134 |
| 3 | NME1 | 6.11289371 |
| 4 | RIPK1 | 5.21946139 |
| 5 | EIF2AK3 | 4.61341397 |
| 6 | ITK | 3.90232106 |
| 7 | BMPR2 | 3.65598630 |
| 8 | PIK3CA | 3.60215264 |
| 9 | MAP4K1 | 3.26968134 |
| 10 | MAP3K14 | 2.98751044 |
| 11 | EIF2AK1 | 2.98063717 |
| 12 | PKN2 | 2.47251411 |
| 13 | MAP2K6 | 2.46345345 |
| 14 | MYLK | 2.32955779 |
| 15 | CDC7 | 2.30803034 |
| 16 | PAK4 | 2.29943286 |
| 17 | CSK | 2.24836791 |
| 18 | EPHB1 | 2.16483094 |
| 19 | TNK2 | 2.09322906 |
| 20 | IRAK4 | 2.04218918 |
| 21 | WNK1 | 1.91993400 |
| 22 | JAK3 | 1.83119870 |
| 23 | IRAK2 | 1.78553279 |
| 24 | FLT3 | 1.77864511 |
| 25 | IKBKE | 1.74616388 |
| 26 | TBK1 | 1.71177611 |
| 27 | VRK2 | 1.64125188 |
| 28 | LCK | 1.58520850 |
| 29 | BTK | 1.57430528 |
| 30 | FGFR3 | 1.54597532 |
| 31 | PIM2 | 1.54424228 |
| 32 | TEC | 1.40871892 |
| 33 | ADRBK2 | 1.38348907 |
| 34 | ZAP70 | 1.33902405 |
| 35 | IKBKB | 1.28647201 |
| 36 | FGFR1 | 1.17830460 |
| 37 | IRAK1 | 1.16455654 |
| 38 | HCK | 1.06920010 |
| 39 | FYN | 0.92241537 |
| 40 | FES | 0.90480548 |
| 41 | TSSK6 | 0.87581504 |
| 42 | DAPK1 | 0.86710220 |
| 43 | CLK1 | 0.85507019 |
| 44 | TLK1 | 0.84939916 |
| 45 | LYN | 0.83298093 |
| 46 | MAP3K5 | 0.83236560 |
| 47 | ZAK | 0.83199998 |
| 48 | PINK1 | 0.82438838 |
| 49 | MST4 | 0.81484061 |
| 50 | AKT3 | 0.81476798 |
| 51 | PRKD3 | 0.80618012 |
| 52 | CSNK1A1L | 0.79087933 |
| 53 | SYK | 0.77375698 |
| 54 | ROCK2 | 0.75289081 |
| 55 | VRK1 | 0.74973231 |
| 56 | PLK3 | 0.73049450 |
| 57 | GRK6 | 0.72131954 |
| 58 | PTK6 | 0.67327393 |
| 59 | BUB1 | 0.65824114 |
| 60 | CAMKK2 | 0.65272590 |
| 61 | JAK1 | 0.63522272 |
| 62 | WNK4 | 0.63201399 |
| 63 | CSNK1G3 | 0.62672445 |
| 64 | ILK | 0.61053665 |
| 65 | PRKCH | 0.60858051 |
| 66 | PKN1 | 0.58478793 |
| 67 | EPHB2 | 0.58257472 |
| 68 | STK10 | 0.56479402 |
| 69 | DAPK3 | 0.56448385 |
| 70 | IGF1R | 0.54251483 |
| 71 | INSR | 0.53841649 |
| 72 | PDK1 | 0.53814486 |
| 73 | GSK3A | 0.52744947 |
| 74 | FGFR4 | 0.51547960 |
| 75 | BLK | 0.48714435 |
| 76 | PAK2 | 0.48215795 |
| 77 | ADRBK1 | 0.47695003 |
| 78 | GRK1 | 0.46958889 |
| 79 | TYK2 | 0.45346677 |
| 80 | GRK7 | 0.44171501 |
| 81 | RPS6KA1 | 0.44147511 |
| 82 | IRAK3 | 0.43860944 |
| 83 | LRRK2 | 0.43448784 |
| 84 | TTN | 0.42803741 |
| 85 | RPS6KB1 | 0.42077658 |
| 86 | CSNK1G1 | 0.40438638 |
| 87 | NUAK1 | 0.40317276 |
| 88 | CSNK1G2 | 0.39964223 |
| 89 | CAMK1D | 0.39658709 |
| 90 | NEK6 | 0.39330574 |
| 91 | TRIM28 | 0.37711418 |
| 92 | PDGFRB | 0.36644160 |
| 93 | RAF1 | 0.36254421 |
| 94 | ALK | 0.35463535 |
| 95 | BMPR1B | 0.34753274 |
| 96 | NME2 | 0.33266699 |
| 97 | KDR | 0.32153892 |
| 98 | BCR | 0.31949393 |
| 99 | PRKCD | 0.31862788 |
| 100 | PTK2B | 0.30819826 |
| 101 | CHUK | 0.30469307 |
| 102 | CDK4 | 0.29809439 |
| 103 | EIF2AK2 | 0.29406924 |
| 104 | CAMKK1 | 0.28905327 |
| 105 | STK24 | 0.28151880 |
| 106 | MAP3K7 | 0.28078974 |
| 107 | TAOK3 | 0.26984922 |
| 108 | SRC | 0.26945816 |
| 109 | MAPKAPK2 | 0.25911573 |
| 110 | MELK | 0.25324982 |
| 111 | ERBB3 | 0.25061222 |
| 112 | MTOR | 0.25031798 |
| 113 | ABL1 | 0.24435152 |
| 114 | BRSK1 | 0.23701671 |
| 115 | KIT | 0.22567114 |
| 116 | NEK1 | 0.22347323 |
| 117 | PDPK1 | 0.22065075 |
| 118 | MAPK9 | 0.21997674 |
| 119 | TTK | 0.21279908 |
| 120 | PRKCA | 0.20993952 |
| 121 | CSNK1A1 | 0.20008442 |
| 122 | MAP2K7 | 0.19894553 |
| 123 | EGFR | 0.19875672 |
| 124 | MAPK10 | 0.19412088 |
| 125 | PRKCB | 0.19381207 |
| 126 | PIM1 | 0.17969756 |
| 127 | CDK5 | 0.16475081 |
| 128 | MAP3K11 | 0.16202941 |
| 129 | STK4 | 0.16079107 |
| 130 | PRKCQ | 0.15514269 |
| 131 | RIPK4 | 0.15483923 |
| 132 | SIK2 | 0.15265809 |
| 133 | PRKG2 | 0.14945682 |
| 134 | CSNK2A2 | 0.14704994 |
| 135 | PTK2 | 0.14687192 |
| 136 | MAPK8 | 0.14089618 |
| 137 | RPS6KB2 | 0.13625743 |
| 138 | MAPK3 | 0.13308791 |
| 139 | BRSK2 | 0.12843508 |
| 140 | SRPK1 | 0.12651861 |
| 141 | ATR | 0.12405362 |
| 142 | CSNK1E | 0.12209815 |
| 143 | JAK2 | 0.11173080 |
| 144 | BCKDK | 0.10964695 |
| 145 | ACVR1B | 0.10051324 |
| 146 | CAMK2B | 0.09746802 |
| 147 | RPS6KA3 | 0.09648697 |
| 148 | PRKDC | 0.09022794 |
| 149 | STK39 | 0.08981191 |
| 150 | PRKACA | 0.08909686 |
| 151 | DAPK2 | 0.08209796 |
| 152 | STK11 | 0.07940167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 7.92936635 |
| 2 | * Proteasome_Homo sapiens_hsa03050 | 6.23917038 |
| 3 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.94677576 |
| 4 | * Allograft rejection_Homo sapiens_hsa05330 | 3.90241506 |
| 5 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.81533585 |
| 6 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.72354862 |
| 7 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.46145776 |
| 8 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 3.32930915 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.02709683 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.92172943 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31938306 |
| 12 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.25434860 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.24324598 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08127448 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04783048 |
| 16 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.85702478 |
| 17 | * Measles_Homo sapiens_hsa05162 | 1.73103336 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58341865 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57183095 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56354740 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.43363753 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41734750 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39779436 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.32435889 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31942952 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.31924181 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31794831 |
| 28 | * Salmonella infection_Homo sapiens_hsa05132 | 1.28790365 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.25195419 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22724412 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16395660 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14896275 |
| 33 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05774535 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04867548 |
| 35 | * Leishmaniasis_Homo sapiens_hsa05140 | 1.03394868 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94974326 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94964068 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90522383 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86485402 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 0.81990383 |
| 41 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.81374590 |
| 42 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80809935 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79216727 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78979469 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78893478 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78013903 |
| 47 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77234293 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76262867 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73620488 |
| 50 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.72332972 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70356584 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70258030 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66011267 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.64428073 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63821028 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 0.63042444 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62150172 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60517104 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59429620 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59198853 |
| 61 | * Malaria_Homo sapiens_hsa05144 | 0.57381655 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 0.57014971 |
| 63 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.56354615 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54535151 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54523977 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53682415 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53502557 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53015029 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.52695257 |
| 70 | * Amoebiasis_Homo sapiens_hsa05146 | 0.52578493 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.52147908 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51815755 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50742642 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48389965 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47479811 |
| 76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47269165 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46171127 |
| 78 | Protein export_Homo sapiens_hsa03060 | 0.44988445 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42097129 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40272480 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39609048 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.39167470 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39061656 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.39045652 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.38734148 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35751543 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35368927 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34881437 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.34131324 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.33737344 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33522701 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33293225 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32985620 |
| 94 | Legionellosis_Homo sapiens_hsa05134 | 0.31496879 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31486070 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31439969 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.30868885 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29083018 |
| 99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.27313099 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27046851 |
| 101 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26444943 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24235558 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22794776 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21274549 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21229470 |
| 106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.18785741 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18619162 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17446980 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.17162210 |
| 110 | * Influenza A_Homo sapiens_hsa05164 | 0.17021186 |
| 111 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16095211 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15417345 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.14642537 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.14227306 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14149014 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14142068 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.13464612 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13388784 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12862810 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.12733880 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.12679232 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12070181 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11827818 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11718410 |
| 125 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.11382435 |
| 126 | Ribosome_Homo sapiens_hsa03010 | 0.11294608 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.11066821 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.10315783 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | 0.09416303 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.09091889 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08194867 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06810927 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.06767238 |
| 134 | * Tuberculosis_Homo sapiens_hsa05152 | 0.06502708 |
| 135 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.05870736 |
| 136 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.05219661 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.04933659 |
| 138 | Huntingtons disease_Homo sapiens_hsa05016 | 0.04527958 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03568569 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.03123592 |
| 141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.03021882 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.02560154 |
| 143 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.02480568 |
| 144 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.02453309 |
| 145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.01760696 |
| 146 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.01539843 |
| 147 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.01237604 |
| 148 | Mineral absorption_Homo sapiens_hsa04978 | 0.00732979 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.00329849 |

